HEPA Projected Dividend Yield
Hepion Pharmaceuticals Inc ( NASDAQ : HEPA )Hepion Pharmaceuticals is a biopharmaceutical company focused primarily on the development of drug therapy for treatment of chronic fibrosis related diseases. The main therapeutic approach specifically targets the disease mechanism related to fibrosis as well as, inflammation and shows potential for the treatment of non-alcoholic steatohepatitis, hepatocellular carcinoma, viral hepatitis, and other fibrotic diseases. Co.'s cyclophilin inhibitor, rencofilstat, is being developed to address multiple pathologies related to advanced fibrotic diseases. Rencofilstat is a pan cyclophilin inhibitor that targets multiple pathologic pathways involved in the progression of fibrosis. 20 YEAR PERFORMANCE RESULTS |
HEPA Dividend History Detail HEPA Dividend News HEPA Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |